E 7010

Known as: E-7010, E7010 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2018
012319932018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Based on our previous results and literature precedence, a series of 2-anilinopyridinyl-benzothiazole Schiff bases were… (More)
Is this relevant?
2016
2016
A series of colchicine site binding tubulin inhibitors were designed and synthesized by the modification of the combretastatin A… (More)
Is this relevant?
2007
2007
A series of novel diaryl ethers possessing various functional groups were synthesized and evaluated for antiproliferative… (More)
Is this relevant?
2002
2002
A series of small molecules from sulfonamide-focused libraries have been evaluated in these laboratories to discover novel… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
2002
2002
Compounds from sulfonamide-focused libraries have been evaluated in cell-based antitumor screens using the COMPARE analysis with… (More)
Is this relevant?
2000
2000
Purpose: E7010 is an orally active sulfonamide antitumor agent showing good activity against various subcutaneously inoculated… (More)
Is this relevant?
1999
1999
Described herein is the discovery of a novel series of antitumor sulfonamides targeting G1 phase of the cell cycle. Cell cycle… (More)
Is this relevant?
1998
1998
E7010 is a novel sulfonamide which was discovered using slow-growing colon 38 carcinoma cells as a screening model. E7010… (More)
  • table 1
  • table 2
  • table 3
  • table 5
  • table 4
Is this relevant?
1997
1997
E7010 (N-[2-[(4-hydroxyphenyl)amino]-3-pyridinyl]-4-methoxybenzenesulfonami de), an orally active sulfonamide antitumor agent… (More)
Is this relevant?
1994
1994
The search for compounds active against solid tumors has led us to the discovery of a novel sulfonamide, E7010 (N-[2-[(4… (More)
  • figure I
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?